Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Ronald N. Marcus"'
Publikováno v:
European Neuropsychopharmacology. 48:45-46
Autor:
Gianpiera Ceresoli-Borroni, Ronald N. Marcus, Stefan Schwabe, Azmi Nasser, Adelaide S. Robb, Chungping Yu, Robert L. Findling, Shawn A. Candler
Publikováno v:
Postgraduate medicine. 131(2)
Proper drug categorization enables clinicians to readily identify the agents most appropriate for patients in need. Currently, patients with maladaptive aggression do not all always fall into a single existing diagnostic or treatment category. Such i
Publikováno v:
CNS Spectrums. 24:177-178
Study ObjectivesAlthough stimulants are commonly used for attention-deficit/hyperactivity disorder (ADHD), 10–30% of patients have an inadequate response, adverse events, or comorbidities preventing use. Thus, there is a need for safe, effective no
Autor:
Robert D. McQuade, Robert M. Berman, James M. Eudicone, John J. Sheehan, Kimberly K. Laubmeier, Ronald N. Marcus, Ross A. Baker, J. Craig Nelson, Zia Rahman
Publikováno v:
CNS Spectrums
IntroductionEfficacy of depression treatments, including adjunctive antipsychotic treatment, has not been explored for patients with worsening symptoms after antidepressant therapy (ADT).MethodsThis post-hoc analysis utilized pooled data from 3 simil
Autor:
S.V. Marler, Gwen Stockton, Ronald N. Marcus, Robert D. McQuade, Raymond Mankoski, George Manos, Robert A. Forbes
Publikováno v:
Journal of Child and Adolescent Psychopharmacology. 23:572-576
The purpose of this study was to evaluate the impact of prior antipsychotic exposure (PAE) on safety and tolerability outcomes in pediatric subjects receiving aripiprazole treatment.This study was a post-hoc analysis of pooled data from two 8-week, d
Autor:
Robert M. Berman, Elizabeth E. Bellocchio, Robert D. McQuade, Ross A. Baker, James Craig Nelson, Ronald N. Marcus, Michael E. Thase, Linda Rollin, James M. Eudicone
Publikováno v:
International Clinical Psychopharmacology. 27:125-133
To evaluate the efficacy of adjunctive aripiprazole in patients with minimal response to prior antidepressant therapy (ADT). Pooled data from three randomized, double-blind, placebo-controlled studies assessing the efficacy of adjunctive aripiprazole
Autor:
Berit X. Carlson, James M. Eudicone, Michael E. Thase, Robert D. McQuade, Ronald N. Marcus, Charles L. Bowden, Michael Nashat
Publikováno v:
International Journal of Psychiatry in Clinical Practice. 16:121-131
This post-hoc analysis of pooled data from two similarly designed trials assessed the impact of aripiprazole monotherapy vs. placebo on treatment outcomes based on baseline severity of core depressive symptoms in patients with bipolar I disorder.Pati
Autor:
William H. Carson, Ronald N. Marcus, Christine Baudelet, Rif S. El-Mallakh, Randall Owen, Robert D. McQuade
Publikováno v:
Journal of Affective Disorders. 136:258-266
Background This study followed manic or mixed bipolar I subjects for an additional 40 weeks after initial randomization to 12 weeks of lithium versus aripiprazole monotherapy. This is the only long-term, double-blind study comparing lithium and aripi
Autor:
Karen Timko, Robert D. McQuade, Estelle Vester-Blokland, Ronald N. Marcus, Terence A. Ketter, Berit X. Carlson, Raymond Sanchez, Wei Sun
Publikováno v:
Bipolar Disorders. 14:41-53
Carlson BX, Ketter TA, Sun W, Timko K, McQuade RD, Sanchez R, Vester-Blokland E, Marcus R. Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, doubl
Autor:
Robert D. McQuade, Ronald N. Marcus, Rif S. El Mallakh, Eduard Vieta, William H. Carson, Linda Rollin
Publikováno v:
European Neuropsychopharmacology. 20:776-783
This study evaluated the efficacy and safety of two fixed doses of aripiprazole (15 mg/day, n = 131 and 30 mg/day, n = 136) compared with placebo (n = 134) in acutely manic or mixed bipolar I hospitalized patients. The mean change from baseline to We